[1] Shin J, Chung JW, Park MS, Lee H, Cha J, Seo WK, Kim GM, Bang OY. Outcomes after ischemic stroke caused by intracranial atherosclerosis vs dissection[J]. Neurology, 2018, 91:E1751-1759. [2] Yan A, Cai G, Fu N, Feng Y, Sun J, Maimaiti Y, Zhou W, Fu Y. Relevance study on cerebral infarction and resistin gene polymorphism in chinese han population[J]. Aging Dis, 2016, 7: 593-603. [3] Wang Y, Zhao X, Liu L, Soo YO, Pu Y, Pan Y, Wang Y, Zou X, Leung TW, Cai Y, Bai Q, Wu Y, Wang C, Pan X, Luo B, Wong KS; CICAS Study Group. Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in china: the chinese intracranial atherosclerosis (CICAS) study[J]. Stroke, 2014, 45:663-669. [4] Hilal S, Xu X, Ikram MK, Vrooman H, Venketasubramanian N, Chen C. Intracranial stenosis in cognitive impairment and dementia[J]. J Cereb Blood Flow Metab, 2017, 37:2262-2269. [5] Kelley AS, McGarry K, Gorges R, Skinner JS. The burden of health care costs for patients with dementia in the last 5 years of life[J]. Ann Intern Med, 2015, 163:729-736. [6] Caplan LR. Vertebrobasilar disease[J]. Adv Neurol, 2003, 92: 131-140. [7] Kocer A. Cognitive problems related to vertebrobasilar circulation[J]. Turk J Med Sci, 2015, 45:993-997. [8] Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial[J]. Lancet, 2014, 383:333-341. [9] Zaidat OO, Fitzsimmons BF, Woodward BK, Wang Z, Killer-Oberpfalzer M, Wakhloo A, Gupta R, Kirshner H, Megerian JT, Lesko J, Pitzer P, Ramos J, Castonguay AC, Barnwell S, Smith WS, Gress DR; VISSIT Trial Investigators. Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial[J]. JAMA, 2015, 313:1240-1248. [10] Sangha RS, Naidech AM, Corado C, Ansari SA, Prabhakaran S. Challenges in the medical management of symptomatic intracranial stenosis in an urban setting[J]. Stroke, 2017, 48: 2158-2163. [11] Alexander MJ, Zauner A, Chaloupka JC, Baxter B, Callison RC, Gupta R, Song SS, Yu W; WEAVE Trial Sites and Interventionalists. Weave trial: final results in 152 on-label patients[J]. Stroke, 2019, 50:889-894. [12] Pucite E, Krievina I, Miglane E, Erts R, Krievins D, Millers A. Changes in cognition, depression and quality of life after carotid stenosis treatment[J]. Curr Neurovasc Res, 2019, 16:47-62. [13] Akioka N, Takaiwa A, Kashiwazaki D, Kuwayama N, Endo S, Kuroda S. Clinical significance of hemodynamic cerebral ischemia on cognitive function in carotid artery stenosis: a prospective study before and after revascularization[J]. Q J Nucl Med Mol Imaging, 2017, 61:323-330. [14] Wang T, Mei B, Zhang J. Atherosclerotic carotid stenosis and cognitive function[J]. Clin Neurol Neurosurg, 2016, 146:64-70. [15] Turan TN, Smock A, Cotsonis G, Bachman D, Al Kasab S, Lynn MJ, Nizham A, Derdeyn CP, Fiorella D, Janis S, Lane B, Montgomery J, Chimowitz MI; SAMMPRIS Investigators. Is there benefit from stenting on cognitive function in intracranial atherosclerosis[J]? Cerebrovasc Dis, 2017, 43:31-35. [16] Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis[J]. N Engl J Med, 2005, 352:1305-1316. [17] Turan TN, Al Kasab S, Smock A, Cotsonis G, Bachman D, Lynn MJ, Nizam A, Derdeyn CP, Fiorella D, Janis S, Lane B, Montgomery J, Chimowitz MI; MBChB for the SAMMPRIS Investigators. Impact of baseline features and risk factor control on cognitive function in the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial[J]. Cerebrovasc Dis, 2019, 47:24-31. [18] Bash S, Villablanca JP, Jahan R, Duckwiler G, Tillis M, Kidwell C, Saver J, Sayre J. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography[J]. AJNR Am J Neuroradiol, 2005, 26:1012-1021. [19] Zhang Y, Rajah GB, Liu P, Sun Y, Liu T, Li X, Miao Z, Li G. Balloon-mounted versus self-expanding stents for symptomatic intracranial vertebrobasilar artery stenosis combined with poor collaterals[J]. Neurol Res, 2019, 41:704-713. [20] O'Driscoll C, Shaikh M. Cross-cultural applicability of the montreal cognitive assessment (MoCA): a systematic review[J]. J Alzheimers Dis, 2017, 58:789-801. [21] Ito Y, Matsumaru Y, Suzuki K, Matsumura A. Impaired cognitive function due to cerebellar infarction and improvement after stent-assisted angioplasty for intracranial vertebral artery stenosis: case report[J]. Neurol Med Chir (Tokyo), 2010, 50:135-138. [22] Yan Y, Liang L, Yuan Y, Chen T, Shen Y, Zhong C. Influence of stent-assisted angioplasty on cognitive function and affective disorder in elderly patients with symptomatic vertebrobasilar artery stenosis[J]. Med Sci Monit, 2014, 20:1129-1136. [23] Wei W, Yi X, Ruan J, Duan X, Luo H, Lv Z. Influence of collateral circulation on cerebral blood flow and frontal lobe cognitive function in patients with severe internal carotid artery stenosis[J]. BMC Neurol, 2019, 19:151. [24] Cosgrove J, Alty JE, Jamieson S. Cognitive impairment in parkinson's disease[J]. Postgrad Med J, 2015, 91:212-220. [25] Xia ZY, Sun QJ, Yang H, Zhang MX, Ban R, Xu GL, Wu YP, Wang le X, Du YF. Effect of carotid artery stenting on cognitive function in patients with internal carotid artery stenosis and cerebral lacunar infarction: a 3-year follow-up study in China[J]. PLoS One, 2015, 10:E0129917. [26] Yoshida J, Yamashita F, Sasaki M, Yoshioka K, Fujiwara S, Kobayashi M, Yoshida K, Kubo Y, Ogasawara K. Adverse effects of pre-existing cerebral small vessel disease on cognitive improvement after carotid endarterectomy[J]. Int J Stroke, 2019: ID1747493019874732. [27] Maggio P, Altamura C, Lupoi D, Paolucci M, Altavilla R, Tibuzzi F, Passarelli F, Arpesani R, Di Giambattista G, Grasso RF, Luppi G, Fiacco F, Silvestrini M, Pasqualetti P, Vernieri F. The role of white matter damage in the risk of periprocedural diffusion-weighted lesions after carotid artery stenting[J]. Cerebrovasc Dis Extra, 2017, 7:1-8. [28] Ogawa Ito A, Shindo A, Ii Y, Matsuura K, Tabei KI, Maeda M, Umino M, Suzuki Y, Shiba M, Toma N, Suzuki H, Tomimoto H. Microbleeds after carotid artery stenting: small embolism may induce cerebral microbleeds[J]. Cerebrovascular Dis Extra, 2019, 9:57-65. [29] Yu C, Guo WC, Zhu L, Tan JY, Shi WH, Zhang XL, Gu YX, Han X, Dong Q. Effect of white matter changes on risk score for peri-procedural complications after carotid artery stenting[J]. Clin Neurol Neurosurg, 2018, 164:108-113. [30] Sigurdsson S, Aspelund T, Kjartansson O, Gudmundsson EF, Jonsdottir MK, Eiriksdottir G, Jonsson PV, van Buchem MA, Gudnason V, Launer LJ. Incidence of brain infarcts, cognitive change, and risk of dementia in the general population: the ages-Reykjavik study (age gene/environment susceptibility-Reykjavik study)[J]. Stroke, 2017, 48:2353-2360. [31] Zhang Y, Sun Y, Li X, Liu T, Liu P, Wang H, Ding J, Miao ZR, Li G. Early versus delayed stenting for intracranial atherosclerotic artery stenosis with ischemic stroke[J]. J Neurointerv Surg, 2020, 12:274-278. [32] Park KC, Yoon SS, Rhee HY. Executive dysfunction associated with stroke in the posterior cerebral artery territory[J]. J Clin Neurosci, 2011, 18:203-208. [33] Kumral E, Zirek O. Major neurocognitive disorder following isolated hippocampal ischemic lesions[J]. J Clin Neurosci, 2017, 372:496-500. [34] Kumral E, Deveci EE, Erdogan C, Enüstün C. Isolated hippocampal infarcts: vascular and neuropsychological findings[J]. J Neurol Sci, 2015, 356:83-89. [35] Hoffmann M, Cases LB. Etiology of frontal network syndromes in isolated subtentorial stroke[J]. Behav Neurol, 2008, 20:101-105. [36] Park KC, Yoon SS, Seo KH. Splenium or parahippocampus involvement and its relationship to cognitive decline in posterior cerebral artery infarction[J]. J Clin Neurosci, 2009, 16:914-917. [37] Abuzinadah AR, Alanazy MH, Almekhlafi MA, Duan Y, Zhu H, Mazighi M, Lutsep HL, Donnon T, Hill MD. Stroke recurrence rates among patients with symptomatic intracranial vertebrobasilar stenoses: systematic review and meta-analysis[J]. J Neurointerv Surg, 2016, 8:112-116. [38] Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study[J]. Ann Neurol, 2005, 57:789-794. [39] Watanabe J, Ogata T, Tsuboi Y, Inoue T. Impact of cerebral large-artery disease and blood flow in the posterior cerebral artery territory on cognitive function[J]. J Neurol Sci, 2019, 402:7-11. [40] Liu M, Nie ZY, Li RR, Zhang W, Wang H, He YS, Zhao LJ, Li YX. Correlation of brain perfusion with white matter hyperintensity, brain atrophy, and cognition in patients with posterior cerebral artery stenosis and subjective cognitive decline[J]. Med Sci Monit, 2018, 24:5729-5738. [41] Norling AM, Marshall RS, Pavol MA, Howard G, Howard V, Liebeskind D, Huston J 3rd, Lal BK, Brott TG, Lazar RM. Is hemispheric hypoperfusion a treatable cause of cognitive impairment[J]? Curr Cardiol Rep, 2019, 21:4. [42] Chen YH, Lin MS, Lee JK, Chao CL, Tang SC, Chao CC, Chiu MJ, Wu YW, Chen YF, Shih TF, Kao HL. Carotid stenting improves cognitive function in asymptomatic cerebral ischemia[J]. Int J Cardiol, 2012, 157:104-107. [43] Liu H, Zhang J. Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress[J]. Int J Neurosci, 2012, 122:494-499. [44] Daulatzai MA. Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease[J]. J Neurosci Res, 2017, 95:943-972. [45] Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (finger): a randomised controlled trial[J]. Lancet, 2015, 385: 2255-2263. [46] Mi T, Qu CQ, Wang X, Sun QJ, Sun H, Du YF. Characteristics of cognitive impairment of different infarct locations among patients after acute ischemic stroke[J]. Zhonghua Yi Xue Za Zhi, 2016, 96:1205-1207.[宓特, 屈传强, 王翔, 孙钦建, 孙昊,杜怡峰. 不同部位急性脑梗死的认知功能障碍特点分析[J].中华医学杂志, 2016, 96:1205-1207.] |